Clinical profile and management of a Spanish single-center retrospective cohort of patients with post-chikungunya associated complications

被引:0
作者
Calle-Prieto, Fernando de la [1 ]
Barriga, Juan J. [2 ]
Arsuaga, Marta [1 ]
de Miguel, Rosa [1 ]
Diaz-Menendez, Marta [1 ]
机构
[1] La Paz Carlos III Univ Hosp, Natl Referral Unit Imported Dis & Int Hlth, High Level Isolat Unit, CIBERINFEC, Madrid, Spain
[2] Bavarian Nord, Med Strategy Dept, Madrid, Spain
关键词
Chikungunya; Endemic; Outbreak; Chronic; Symptoms; QUALITY-OF-LIFE; VIRUS; INFECTION; EPIDEMIOLOGY; PATHOGENESIS; AMERICA; FEVER;
D O I
10.1016/j.tmaid.2024.102726
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study aims to describe post-chikungunya complications chronically developed cases in returning travelers from some epidemic/endemic regions, and the variables that are associated with the progression of acute or subacute cases to the chronic phase. Methods: This single -center retrospective cohort study included chikungunya fever cases treated at La Paz -Carlos III University Hospital in Madrid, Spain, April 2014 to September 2016, when the chikungunya outbreak in Latin America started through the time of its greatest impact. Results: The analysis included 119 cases. Of these, 67.2 % were male, with a median age of 41.0 years [IQR 16.0 to 76.0] years. Only 25.6 % of the patients attended a pre -travel advice consultation. Most patients reported arthralgias, which significantly impacted their daily quality of life (86 %). The mean duration of joint symptoms was 129.4 days, with a median of 90 days [IQR 0 to 715]. Factors found to be associated with chronic arthralgia include female sex, country of infection, age at diagnosis, previous diseases, symptoms during the acute phase, pain in previously injured tendons/joints, acute phase severity, and various laboratory markers such as hemoglobin, hematocrit, total serum bilirubin, and creatinine. Progression to chronic arthralgia significantly increased the need for changes in daily activity. Furthermore, 42.6 % of patients with chronic arthralgia reported recurrence of symptoms once they felt they had disappeared. Targeted treatment regimens led to significant improvements in these patients. Conclusions: The results of this study underscore the need for: (1) comprehensive pre -travel advice; (2) effective management of patients in specialized units, alongside early diagnosis and treatment, to prevent trivialization of these viral infections; and (3) the development of interdisciplinary recommendations to assist physicians in treating patients and enhancing outcomes.
引用
收藏
页数:6
相关论文
共 24 条
[11]   Chikungunya chronic disease: a systematic review and meta-analysis [J].
Paixao, Enny S. ;
Rodrigues, Laura C. ;
Costa, Maria da Conceicao N. ;
Itaparica, Martha ;
Barreto, Florisneide ;
Gerardin, Patrick ;
Teixeira, Maria Gloria .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2018, 112 (07) :301-316
[12]   Impact of Chikungunya on Health Related Quality of Life Chennai, South India [J].
Ramachandran, Vidya ;
Malaisamy, Muniyandi ;
Ponnaiah, Manickam ;
Kaliaperuaml, Kanagasabai ;
Vadivoo, Selvaraj ;
Gupte, Mohan Digambar .
PLOS ONE, 2012, 7 (12)
[13]   Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis [J].
Rodriguez-Morales, Alfonso J. ;
Cardona-Ospina, Jaime A. ;
Fernanda Urbano-Garzon, Sivia ;
Sebastian Hurtado-Zapata, Juan .
ARTHRITIS CARE & RESEARCH, 2016, 68 (12) :1849-1858
[14]   The Intolerable Burden of Chikungunya: What's New, What's Needed? [J].
Saxena, Shailendra K. ;
Swamy, M. L. Arvinda ;
Verma, Sunil K. ;
Saxena, Rakhi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES INDIA SECTION B-BIOLOGICAL SCIENCES, 2012, 82 (01) :153-165
[15]   Biology and pathogenesis of chikungunya virus [J].
Schwartz, Olivier ;
Albert, Matthew L. .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (07) :491-500
[16]   Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies [J].
Silva, Laurie A. ;
Dermody, Terence S. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03) :737-749
[17]   French guidelines for the management of chikungunya (acute and persistent presentations). November 2014 [J].
Simon, F. ;
Javelle, E. ;
Cabie, A. ;
Bouquillard, E. ;
Troisgros, O. ;
Gentile, G. ;
Leparc-Goffart, I. ;
Hoen, B. ;
Gandjbakheh, F. ;
Rene-Corail, P. ;
Franco, J. -M. ;
Caumes, E. ;
Combe, B. ;
Poiraudeau, S. ;
Gane-Troplent, F. ;
Djossou, F. ;
Sehaerverbeke, T. ;
Criquet-Hayot, A. ;
Carrere, P. ;
Malvy, D. ;
Gaillard, P. ;
Wendling, D. .
MEDECINE ET MALADIES INFECTIEUSES, 2015, 45 (07) :243-263
[18]   Chikungunya virus infection [J].
Simon F. ;
Javelle E. ;
Oliver M. ;
Leparc-Goffart I. ;
Marimoutou C. .
Current Infectious Disease Reports, 2011, 13 (3) :218-228
[19]   Chikungunya Virus in the Americas - What a Vectorborne Pathogen Can Do [J].
Staples, J. Erin ;
Fischer, Marc .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (10) :887-889
[20]   Chikungunya Fever: An Epidemiological Review of a Re-Emerging Infectious Disease [J].
Staples, J. Erin ;
Breiman, Robert F. ;
Powers, Ann M. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (06) :942-948